Speaker illustration

Doctor Alberto Juan Lorenzatti

DAMIC Medical Institute, Cordoba (Argentina)

Dr. Alberto J. Lorenzatti is Co-Director at the DAMIC Medical Institute / Rusculleda Foundation for Research. University Degrees: Medical Doctor, National Córdoba University, School of Medicine, 1980. Specialist in Cardiology, National Córdoba University, 1988. Certified Clinical Lipidologist, Argentine Lipid Society, 2014. Certified Medical Expert in Clinical Research and Pharmacology, Cordoba Medical Council, 2016. Invited Professor of Internal Medicine, Cordoba National University, Argentina (current), Teacher of Postgraduate in Cardiology, Córdoba Hospital (current). President of the Argentine Federation of Cardiology (FAC) 2020. Current Chair of the Americas Federation from the International Atherosclerosis Society. Co-Founder and Ex President of the Argentine Lipids Society (2003-2005) Member of the Board of Directors of the International Society of Cardiovascular Pharmacotherapy (ISCP). Co-Editor European Heart Journal (EHJ). Co-Editor European Cardiology Reviews (ECR)

Achievement of ESC/EAS lipid treatment goals with evolocumab in patients with type 2 diabetes: analyses of the BANTING and BERSON trials

Event: ESC Congress 2020

Topic: Lipids

Session: Risk Factors and Prevention ePosters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk